Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > ICO will go up very quickly to 0.16¢

<< Previous

Bullboard Posts

Next >>

Comment by ForexWhaleon Oct 05, 2018 11:40am

61 Views

Post# 28752367

RE:ICO will go up very quickly to 0.16¢

not until the market hears about ICO-019 fate I think. Based on phase 1 trials this is not moving.

Either IMNP payment or ICO-019 phase 2 funding will send us to 20s again.

I guess money makes the mare go. No one is appreciating the potential. Too early in big investors eyes.

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs